Chapter 3 Flashcards
Sedative drug that, when used during pregnancy, can cause severe developmental damage to a fetus
Thalidomide
Birth defect; impaired development of the arms, legs, or both
Phocomelia
Physical sign, laboratory measurement, radiographic image, or other measure that is expressed to predict clinical benefit but it is not itself a measure of clinical benefit
Surrogate endpoint
Measure of a therapeutic effect that is considered reasonably likely to predict the clinical benefit of a drug, such as an effect on irreversible morbidity and mortality
Intermediate clinical endpoint
FDA policy allowing the change of suitable prescription drugs to over-the-counter status
Switching policy
Drug-reduction policy aimed at reducing the supply of illegal drug and controlling other therapeutic drugs
Supply reduction
Attempts to decrease individuals’ tendencies to use drugs, often aimed at youth, with emphasis on reformulating values and behaviors
Demand reduction
Method of abuse prevention that protects drug users by teaching them responsibility
Inoculation
Process that integrates substance abuse treatment, incentives, and sanctions and places nonviolent, drug-involved defendants in judicially supervised rehabilitation programs
Drug courts
Policy of cutting off or destroying supplies of illicit drugs
Interdiction